Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1509
S.1509: Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced June 29, 2017
- Latest Major Action June 29, 2017
Bill Sponsor
Bill Cosponsors
5 (3 Democrats, 2 Republicans)
Bill Version
- Introduced in Senate - June 29, 2017
Bill Summary
Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017 This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to extend by six months the exclusivity period for an approved drug or biological product when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an orphan disease). The FDA may...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| June 29, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| June 29, 2017 |
Introduced in the Senate by Orrin G. Hatch (R-Utah) |